Trial Profile
A phase II trial of recombinant human parathyroid hormone (1-34)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Calcium carbonate; Elcatonin
- Indications Male osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Shanghai United Cell Biotechnology
- 28 Oct 2015 New trial record